Effect of N-(biphenylyl-methyl)imidazole, a type 1 angiotensin II receptor inhibitor, on the contractile function of the rat corpus cavernosum

Yat Ching Tong, Chia Jane Wang, Paul Chan, Juei Tang Cheng

Research output: Contribution to journalArticle

Abstract

The effect of N-(biphenylyl-methyl)imidazole, losartan potassium, a newly developed antihypertensive type 1 angiotensin II receptor antagonist on the rat erectile function, was studied. Sexually active 9-week-old male spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats were given losartan 60 mg/kg intraperitoneal injections. Mean blood pressure (MBP) dropped significantly in both SHR and WKY rats (for SHR: from 140 ± 8 to 114 ± 5 mm Hg, p <0.05, n = 8; for WKY: from 113 ± 7 to 79 ± 9 mm Hg, p <0.05, n = 8). On the contrary, the intracavernous pressure (ICP) of SHR and WKY rats did not differ significantly from that of the corresponding controls receiving saline injections (p > 0.05, n = 8 for each group). For the chronic study, the rats were fed with losartan 30 mg/kg/day for 30 days. MBP decreased significantly in SHR but not in WKY rats (for SHR: from 137 ± 7 to 113 ± 5 mm Hg, p <0.05, n = 8; for WKY: from 110 ± 6 to 107 ± 5 mm Hg, p > 0.05, n = 8). The ICP of the losartan-treated rats was not significantly different from that of control rats (p > 0.05, n = 8 for each group). In contrast, WKY rats receiving guanethidine 1 mg/kg/day for 30 days showed significantly decreased ICP. Angiotensin II (10-9-10-5 M) and losartan (10-9-10-5 M) did not induce significant contractile responses of the cavernosal strip when tested in vitro. On the other hand, methoxamine 10-4 M induced good contractile responses. In conclusion, the present study demonstrated that angiotensin II did not cause significant change in the contractile status of rat corpus cavernosum. Correspondingly, the type 1 angiotensin II inhibitor effectively lowered blood pressure but did not affect cavernosal contractile function, thus is useful clinically in the treatment of hypertensive disorders without significant detrimental effects on male sexual function. Copyrit (C) 2000 S. Karger G, Basel.

Original languageEnglish
Pages (from-to)149-153
Number of pages5
JournalUrologia Internationalis
Volume64
Issue number3
Publication statusPublished - May 2000

Fingerprint

Angiotensin Type 1 Receptor
Losartan
Inbred SHR Rats
Inbred WKY Rats
Angiotensin II
Blood Pressure
Methoxamine
Angiotensin II Type 1 Receptor Blockers
Guanethidine
Intraperitoneal Injections
Antihypertensive Agents
imidazole

Keywords

  • Angiotensin II
  • Corpus cavernosum
  • Hypertension
  • Impotence

ASJC Scopus subject areas

  • Urology

Cite this

Effect of N-(biphenylyl-methyl)imidazole, a type 1 angiotensin II receptor inhibitor, on the contractile function of the rat corpus cavernosum. / Tong, Yat Ching; Wang, Chia Jane; Chan, Paul; Cheng, Juei Tang.

In: Urologia Internationalis, Vol. 64, No. 3, 05.2000, p. 149-153.

Research output: Contribution to journalArticle

@article{44133e7eac7f4874b5fc6e1299e52f61,
title = "Effect of N-(biphenylyl-methyl)imidazole, a type 1 angiotensin II receptor inhibitor, on the contractile function of the rat corpus cavernosum",
abstract = "The effect of N-(biphenylyl-methyl)imidazole, losartan potassium, a newly developed antihypertensive type 1 angiotensin II receptor antagonist on the rat erectile function, was studied. Sexually active 9-week-old male spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats were given losartan 60 mg/kg intraperitoneal injections. Mean blood pressure (MBP) dropped significantly in both SHR and WKY rats (for SHR: from 140 ± 8 to 114 ± 5 mm Hg, p <0.05, n = 8; for WKY: from 113 ± 7 to 79 ± 9 mm Hg, p <0.05, n = 8). On the contrary, the intracavernous pressure (ICP) of SHR and WKY rats did not differ significantly from that of the corresponding controls receiving saline injections (p > 0.05, n = 8 for each group). For the chronic study, the rats were fed with losartan 30 mg/kg/day for 30 days. MBP decreased significantly in SHR but not in WKY rats (for SHR: from 137 ± 7 to 113 ± 5 mm Hg, p <0.05, n = 8; for WKY: from 110 ± 6 to 107 ± 5 mm Hg, p > 0.05, n = 8). The ICP of the losartan-treated rats was not significantly different from that of control rats (p > 0.05, n = 8 for each group). In contrast, WKY rats receiving guanethidine 1 mg/kg/day for 30 days showed significantly decreased ICP. Angiotensin II (10-9-10-5 M) and losartan (10-9-10-5 M) did not induce significant contractile responses of the cavernosal strip when tested in vitro. On the other hand, methoxamine 10-4 M induced good contractile responses. In conclusion, the present study demonstrated that angiotensin II did not cause significant change in the contractile status of rat corpus cavernosum. Correspondingly, the type 1 angiotensin II inhibitor effectively lowered blood pressure but did not affect cavernosal contractile function, thus is useful clinically in the treatment of hypertensive disorders without significant detrimental effects on male sexual function. Copyrit (C) 2000 S. Karger G, Basel.",
keywords = "Angiotensin II, Corpus cavernosum, Hypertension, Impotence",
author = "Tong, {Yat Ching} and Wang, {Chia Jane} and Paul Chan and Cheng, {Juei Tang}",
year = "2000",
month = "5",
language = "English",
volume = "64",
pages = "149--153",
journal = "Urologia Internationalis",
issn = "0042-1138",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Effect of N-(biphenylyl-methyl)imidazole, a type 1 angiotensin II receptor inhibitor, on the contractile function of the rat corpus cavernosum

AU - Tong, Yat Ching

AU - Wang, Chia Jane

AU - Chan, Paul

AU - Cheng, Juei Tang

PY - 2000/5

Y1 - 2000/5

N2 - The effect of N-(biphenylyl-methyl)imidazole, losartan potassium, a newly developed antihypertensive type 1 angiotensin II receptor antagonist on the rat erectile function, was studied. Sexually active 9-week-old male spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats were given losartan 60 mg/kg intraperitoneal injections. Mean blood pressure (MBP) dropped significantly in both SHR and WKY rats (for SHR: from 140 ± 8 to 114 ± 5 mm Hg, p <0.05, n = 8; for WKY: from 113 ± 7 to 79 ± 9 mm Hg, p <0.05, n = 8). On the contrary, the intracavernous pressure (ICP) of SHR and WKY rats did not differ significantly from that of the corresponding controls receiving saline injections (p > 0.05, n = 8 for each group). For the chronic study, the rats were fed with losartan 30 mg/kg/day for 30 days. MBP decreased significantly in SHR but not in WKY rats (for SHR: from 137 ± 7 to 113 ± 5 mm Hg, p <0.05, n = 8; for WKY: from 110 ± 6 to 107 ± 5 mm Hg, p > 0.05, n = 8). The ICP of the losartan-treated rats was not significantly different from that of control rats (p > 0.05, n = 8 for each group). In contrast, WKY rats receiving guanethidine 1 mg/kg/day for 30 days showed significantly decreased ICP. Angiotensin II (10-9-10-5 M) and losartan (10-9-10-5 M) did not induce significant contractile responses of the cavernosal strip when tested in vitro. On the other hand, methoxamine 10-4 M induced good contractile responses. In conclusion, the present study demonstrated that angiotensin II did not cause significant change in the contractile status of rat corpus cavernosum. Correspondingly, the type 1 angiotensin II inhibitor effectively lowered blood pressure but did not affect cavernosal contractile function, thus is useful clinically in the treatment of hypertensive disorders without significant detrimental effects on male sexual function. Copyrit (C) 2000 S. Karger G, Basel.

AB - The effect of N-(biphenylyl-methyl)imidazole, losartan potassium, a newly developed antihypertensive type 1 angiotensin II receptor antagonist on the rat erectile function, was studied. Sexually active 9-week-old male spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats were given losartan 60 mg/kg intraperitoneal injections. Mean blood pressure (MBP) dropped significantly in both SHR and WKY rats (for SHR: from 140 ± 8 to 114 ± 5 mm Hg, p <0.05, n = 8; for WKY: from 113 ± 7 to 79 ± 9 mm Hg, p <0.05, n = 8). On the contrary, the intracavernous pressure (ICP) of SHR and WKY rats did not differ significantly from that of the corresponding controls receiving saline injections (p > 0.05, n = 8 for each group). For the chronic study, the rats were fed with losartan 30 mg/kg/day for 30 days. MBP decreased significantly in SHR but not in WKY rats (for SHR: from 137 ± 7 to 113 ± 5 mm Hg, p <0.05, n = 8; for WKY: from 110 ± 6 to 107 ± 5 mm Hg, p > 0.05, n = 8). The ICP of the losartan-treated rats was not significantly different from that of control rats (p > 0.05, n = 8 for each group). In contrast, WKY rats receiving guanethidine 1 mg/kg/day for 30 days showed significantly decreased ICP. Angiotensin II (10-9-10-5 M) and losartan (10-9-10-5 M) did not induce significant contractile responses of the cavernosal strip when tested in vitro. On the other hand, methoxamine 10-4 M induced good contractile responses. In conclusion, the present study demonstrated that angiotensin II did not cause significant change in the contractile status of rat corpus cavernosum. Correspondingly, the type 1 angiotensin II inhibitor effectively lowered blood pressure but did not affect cavernosal contractile function, thus is useful clinically in the treatment of hypertensive disorders without significant detrimental effects on male sexual function. Copyrit (C) 2000 S. Karger G, Basel.

KW - Angiotensin II

KW - Corpus cavernosum

KW - Hypertension

KW - Impotence

UR - http://www.scopus.com/inward/record.url?scp=0034083936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034083936&partnerID=8YFLogxK

M3 - Article

C2 - 10859546

AN - SCOPUS:0034083936

VL - 64

SP - 149

EP - 153

JO - Urologia Internationalis

JF - Urologia Internationalis

SN - 0042-1138

IS - 3

ER -